Recognition of a Cardiac Arrest Within the EMS (ACR90)

January 15, 2024 updated by: Hôpital NOVO

Evaluation of the Optimal Time of Recognition of a Cardiac Arrest Within the EMS 95

This study aims to evaluate the average time taken by the Medical Regulation Assistants (MRA) to detect a cardiac arrest during the call to the EMS as well as the factors influencing this delay.

Its main objective is to evaluate the delay, in seconds, between the call being picked up and the recognition of a cardiac arrest by the medical regulation assistant at the EMS 95

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

In France, the incidence of cardiac arrest in adults is approximately 40,000 per year. It is a major cause of mortality with an average survival rate of 8%, as well as morbidity, particularly neurological morbidity for surviving patients. The majority of cardiac arrests occur at In France, the incidence of cardiac arrest in adults is approximately 40,000 per year. It is a major cause of mortality with an average survival rate of 8%, as well as morbidity, particularly neurological morbidity for surviving patients. The majority of cardiac arrests occur at home, in the presence of a witness.

In the event of a cardiac arrest, every minute counts. Studies have shown that the time between the patient's collapse and the start of ECM (External Cardiac Massage) is directly correlated to the survival rate after a cardiac arrest.

According to other studies, a maximum delay of 90 seconds between the call to the EMS and the recognition of the cardiac arrest would be the most optimal for the patient, but is it reached at the EMS 95? This study aims at evaluating the average time taken by the Assistants of Medical Regulation (ARM) to detect a cardiac arrest during the call to the EMS as well as the factors influencing this delay.

Its main objective is to evaluate the delay, in seconds, between the call pick-up and the recognition of a cardiac arrest by the medical regulation assistant at the EMS 95. This evaluation will be made in particular by determining the elements of language highlighting the cardiac arrest, those which lengthen the time of detection of the arrest and the delay of starting a procedure by the ARM. The study will be conducted within the EMS and will include a review of the current state of knowledge and experience of the MRAs. This study will be carried out within the EMS 95.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Medical regulation assistant taking a call from a witness of a cardiac arrest between September 2022 and February 2023

Description

Inclusion Criteria :

- Any call resulting in the detection of a cardiac arrest during ARM regulation: calls to 15 and calls transmitted by 18

Exclusion Criteria :

  • Traumatic context
  • Call involving cardiac arrest already identified as such by the caller or 18
  • Call with criteria of proven death
  • The caller does not speak French, the linguistic elements noted are not usable.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation, of the time elapsed (seconds) between the taking in charge of the call and the recognition of a cardiac arrest by the medical regulation assistant (ARM) of the EMS 95.
Time Frame: At the end of the study, an average of 5 month
Measure of the time in seconds between picking up the phone and the recognition of the cardiac arrest by the medical regulation assistant
At the end of the study, an average of 5 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identify language that highlights cardiac arrest
Time Frame: At the end of the study, an average of 5 month
Collection of the initial reason for appeal and everything said by the witness that may point to cardiac arrest
At the end of the study, an average of 5 month
Identify language that increases the time to detect cardiac arrest
Time Frame: At the end of the study, an average of 5 month
Collection of everything said by the witness increasing the detection of the cardiac arrest
At the end of the study, an average of 5 month
Evaluation of the time required for the MRA to initiate a procedure (AED search: External Automated Defibrillator or initiation of external cardiac massage assistance)
Time Frame: At the end of the study, an average of 5 month

Collection of time (seconds) between :

  • the MRA taking the call and requesting an AED search
  • the MRA taking the call and the start of external cardiac massage
At the end of the study, an average of 5 month
Identification of factors that may influence the time to recognition of cardiac arrest (MRA experience, tone of the call)
Time Frame: At the end of the study, an average of 5 month
Collection of call tone (witness anxiety level) and MRA experience in years
At the end of the study, an average of 5 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hôpital NOVO

Investigators

  • Principal Investigator: Dr Ariane Zoya-Gillet, Hopital Novo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2022

Primary Completion (Estimated)

May 1, 2024

Study Completion (Estimated)

May 1, 2024

Study Registration Dates

First Submitted

August 29, 2022

First Submitted That Met QC Criteria

August 29, 2022

First Posted (Actual)

September 1, 2022

Study Record Updates

Last Update Posted (Actual)

January 17, 2024

Last Update Submitted That Met QC Criteria

January 15, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHRD2321

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Clinical Trials on Time elapsed between the taking in charge of the call and the recognition of a cardiac arrest by the MRA

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe